Efficacy and safety of novel lipoprotein(a)-targeted therapies: A systematic review and meta-analysis of randomised controlled trials

Scritto il 12/12/2025
da Anisio Uchoa Leite Santana

No abstract

Diabetes Obes Metab. 2025 Dec 12. doi: 10.1111/dom.70349. Online ahead of print.

NO ABSTRACT

PMID:41387345 | DOI:10.1111/dom.70349